• Most Popular
  • Most Shared

Togo says to distribute HIV/AIDS drugs at no cost

LOME
Sat Nov 15, 2008 1:57pm EST

LOME (Reuters) - Togo will start distributing free of charge from November 17 the anti-retroviral drugs that extend the lives of HIV/AIDS patients, its government said Saturday.

Health

"Anti-retroviral medicines distributed by the network of the Central Supply of Essential and Generic Medicines (CAMEG) will be free of charge from Monday 17 November throughout the country," an official statement broadcast on state radio said.

Around 25,000 people will benefit from the measure, said Augustin Dokla, who represents a network of HIV/AIDS sufferers, up from 8,000 who already have access to the drugs from CAMEG.

Patients who want to receive the free drugs must register with local medical committees.

Anti-retrovirals bought privately cost between 3,000 and 25,000 CFA francs ($47.53) per month. Such treatment can significantly reduce the level of HIV virus in the blood but transmission risks remain, U.N. health agencies have said.

Since 2006, the rate of HIV infection among the Togolese population has been steady at 3.2 percent, according to official figures.

(Reporting by John Zodzi; Writing by Daniel Magnowski; Editing by Richard Balmforth)



More from Reuters

Photo

Euro zone holds intensive talks about Greek rescue

BERLIN/ATHENS (Reuters) - Euro zone countries were holding intensive talks on Wednesday about a possible financial rescue for debt-stricken Greece as civil servants staged the first major strike against Athens' crisis-driven austerity plan.

Chairman of the Federal Reserve Ben Bernanke testifies before the Senate Banking, Housing and Urban Affairs Committee on Capitol Hill in Washington July 22, 2009. REUTERS/Kevin Lamarque
John Kemp:

The Fed needs a new storyline

It's irrelevant whether the Fed sells its assets back to the market. What matters is whether and when it's prepared to raise rates.  Commentary 

A worker drives a Toyota Motor Corp's newly assembled Prius hybrid vehicle onto a trailer near the company's plant in Toyota, central Japan February 9, 2010.REUTERS/Yuriko Nakao
Reuters Breakingviews:

Toyota's troubles in overdrive

The cost of Toyota's recall nightmare is nothing compared to the price of fixing its battered reputation.  Commentary